We report that a cytokine imbalance appears to contribute to the bone loss in DMD and point to interleukin 6 (IL-6) as a possible systemic mediator of the damage induced by chronic inflammation in bone, which could be subjected to therapeutic neutralization. This evidence concerns the gene IL6 and Duchenne muscular dystrophy.